Biotech Values

[DewDiligence]

Reuters chimes in on Xgeva vote; odd quote from the patient rep on the panel:

http://www.xe.com/news/2012/02/08/2459393.htm

'There isn't a treatment that a man with prostate cancer gets that doesn't have devastating effects on his masculinity and his quality of life,' said James Kiefert, of Olympia, Washington. 'In my opinion, the men who would be candidates for this treatment would be standing up and cheering another option for them.'

His views echoed the favorable comments of several urologists, who testified in favor of the drug during the public hearing.